Pre-conference Workshop
.
Pre-conference Workshop
HIV & Tuberculosis: Choosing the Right Diagnostics to Challenge
Theme: Co-Infection, Collusion, Catastrophe and Casualty
Organized by: Department of Microbiology, Seth GSMC & KEMHospital, Mumbai
Venue: Seminar Hall, 5th Floor, MSB, GSMC & KEMH, Parel, Mumbai 400012
Date: 12th December 2013: 9 am to 5 pm
Tentative Program
| Timing | Topic | Faculty |
09.00 - 09.30 am |
Registration, Breakfast and Pre-workshop evaluation |
|
09.30 - 10.00 am |
Inauguration |
|
10.00 - 10.20 am |
From Co-infection to Casualty – The Story the Numbers tell |
Dr. R. R. Gangakhedkar |
10.20 – 10.40 am |
HIV & TB – Colluding for a Catastrophe |
Dr. Gita Nataraj |
10.40 – 11.00 am |
Tea Break |
|
11.00 – 11.20 am |
Right Diagnostics to Challenge HIV |
Dr. Preeti Mehta |
11.20 – 11.40 am |
Right Diagnostics to Challenge TB |
Dr. Ameeta Joshi |
11.40 – 12.30 pm |
HIV & TB: A clinician’s nightmare |
Dr. A. R. Pazare |
12.30 – 12.45 pm |
Discussion |
|
12.45 – 01.30 pm |
Lunch |
|
01.30 – 04.30 pm |
Demonstration of Conventional and Recent Diagnostic Tests for HIV and TB |
Dr. NayanaIngole, Dr. PurvaSarkate |
04.30- 5.00 pm |
Post workshop evaluation and Valedictory |
Note: Registration Free but Mandatory. The number of participants will be restricted to forty and will be on a first come first serve basis.
Maharashtra Medical Council has granted two credit hours
Contact for registration:
Dr. Nayana Ingole,Asso.Prof., Microbiology Dept, GSMC& KEMH: nayanaingole@gmail.com
HIV and Tuberculosis:Choosing the Right Diagnostics To Challenge
Background:
India, withapproximately 1.3 million notified new cases of TB in 2012 and 44,000 HIV patients co-infected with TB, is staring at a problem of significant magnitude and it has been so for some years. The epidemic is being driven by unsuspected and / or undiagnosed cases. Limitations of conventional diagnostic tests for detection of TB in the HIV infected and vice versa contribute to the silent epidemic. Patients with HIV-TB co-infection also have a higher mortality. In 2010, it was estimated that 1/3rd of the dually infected died.
Compounding this scenario is the problem due to drug resistant TB. India has an MDRTB incidence in new cases of 3% and in retreatment cases of 15-20%. MDRTB co-infection is a significant problem in the HIV infected, with higher rates of MDR TB and significantly higher mortality.
It is only when infected patients are detected accurately early in disease, even in situations where the microbial burden is paucibacillary such as in TB co-infected HIV patients, can the problem be mitigated? Similarly, detecting HIV in TB patients is equally important if not more. Against the backdrop of current epidemiology, identifying the drug resistant status has become as important as detecting the presence of the disease causing agent for both these agents. A variety of newer phenotypic tests with improved detection and a reduced turnaround time are now available. Newer and simpler molecular platforms are beginning to provide hope for individual case management as well as for control of transmission.
The nation is trying its best to control these infections at individual levels as well as through coordinated programmes. TB is a curable disease and antiretroviral therapy is now available. The dual epidemic can be challenged with a concerted effort from all stakeholders beginning with a high index of suspicion. Early diagnosis, treatment and prevention of TB in PLHA (through early ART initiation) and early diagnosis and treatment of HIV in TB patients are essential for this to happen. This requires an understanding of the microbes, the disease, the co-infection, the collusion, and the role of diagnostics in preventing a catastrophe and casualty.
The present workshop has been organized with these objectives in mind. These objectives will be achieved through lectures delivered by experts in their respective fields followed by demonstration on conventional and recent diagnostics for TB and HIV. An understanding of the utility of recent diagnostics in better management of patients and thereby control of disease burden will help both clinicians and diagnostic labs in equal measure.
There is no registration fee, but registration is mandatory as the number of participants will be restricted to forty on a first come first serve basis.
Second Pre-conference Workshop programme
Pre-conference Workshop: Pediatric HIV
Theme: A CASE BASED APPROACH
Organized by: Pediatric HIV Clinic, Department of Pediatrics, B.J.Wadia Hospital for Children
Venue: Dr. S M Merchant Auditorium, B.J.Wadia Hospital for Children, Parel, Mumbai 400012
Date: 12th December 2013: 9.00 am to 12.45 pm
Registration: 9.00-9.30am
Introduction: 9.30-9.40am: Dr Ira Shah
Case discussions: 9.40-11.00am
Tea Break: 11.00am-11.20am
Lunch break: 12:45pm
Programme Highlights
| PPTCT- New WHO guidelines – Is it all that safe? Do not forget metabolic acidosis |
| Functional HIV Cure – HIV ELISA AND PCR becomes negative on ART |
| Protease Inhibitors and anti- TB treatment – What to do with second line ART and AKT together |
| MDR TB in an HIV infected child |
| HIV resistance testing – How to Approach |
| HIV and malignancy |
| HIV and Hepatitis B co-infection |
| And more…… |
The aim of this program is to focus on the rare, difficult and interesting pediatric HIV cases, while at the same time making this workshop as interactive as possible. Discussions by EXPERT PANELISTS (Dr Ira Shah, Dr Mukesh Agrawal, Dr MamathaLala and more….)
Note: Registration Free but Mandatory. The number of participants will be restricted to 100 and will be on a first come first serve basis.
Maharashtra Medical Council has granted two credit hours
Contact for registration:
Dr. Ira Shah,
Incharge-Pediatric HIV Clinic, B.J.Wadia Hospital for Children.
Email: pedconference@gmail.com
Tel: 022-32217624.
Kindly confirm your participation by a return email, telephone with the following details:Name, Affiliation, Mobile and Email Address. We request you to send us yourconfirmation as soon as possible.
Third Pre-conference CME
Date: 12th December 2013
HIV -Hepatitis
A serious grey zone in life of HIV positive person is when he is detected to have hepatitis too.Whether to treat or not to treat, with what drugs to treat .and monitoring of side effects ..Through this workshop, we would like to focus on the different caveats in our knowledge of HIV-Hepatitis
HIV -Pregnancy
Pregnant females are a important group for detection,treatment and control of HIV...Some centres follow single drug regimen ,while some have multidrug regimen....Breast feeding is still a grey zone..Through this workshop we would like to focus on some of these issues
PROGRAMME:
12.00 noon to 1.00pm-Lunch &Registration
1.00pm to 2.30 pm-- HIV & Hepatitis (Dr P.D.Sawant,Dr Meghraj Ingale,Dr Sujata Baweja)
2.30 pm to 2.45pm---tea break
2.45pm to 4.15pm---HIV & Pregnancy, New PPTCT Guidelines (Dr Y.S.Nandanwar, Dr Rekha Dawar, Dr Michelle Fonseca).
Coordinators:
Dr. N.D. Moulick
Dr. Rupal Padhiyar
Kindly Contact:
Dr. N.D. Moulick
Mob: +91 9833022282
Note:
Registration is free but compulsory, limited seats, MMC credit points - 2 points for each workshop, conf. registration is not compulsory for those attending workshops or Conf. Registration is independent of the Workshop registration.